<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" VersionID="2" Owner="NLM" IndexingMethod="Automated"><PMID Version="2">36755319</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>10</Day></DateCompleted><DateRevised><Year>2023</Year><Month>02</Month><Day>15</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1479-5876</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Feb</Month><Day>08</Day></PubDate></JournalIssue><Title>Journal of translational medicine</Title><ISOAbbreviation>J Transl Med</ISOAbbreviation></Journal><ArticleTitle>Alterations in the human oral microbiota in systemic lupus erythematosus.</ArticleTitle><Pagination><StartPage>95</StartPage><MedlinePgn>95</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">95</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12967-023-03892-3</ELocationID><Abstract><AbstractText Label="BACKGROUND">Alterations in oral microbiota in patients with systemic lupus erythematosus (SLE) is less evaluated. The aim of this study was to compare the characteristics of the oral microbiome in SLE patients and healthy controls, and construct an SLE classifier based on the oral microbiota.</AbstractText><AbstractText Label="METHODS">We sequenced tongue-coating samples of individuals in treatment-na&#xef;ve SLE (n&#x2009;=&#x2009;182) and matched healthy controls (n&#x2009;=&#x2009;280). We characterized the oral microbiome and constructed a microbial classifier in the derivation cohort and validated the results in the validation cohorts. Furthermore, the oral microbiome of posttreatment SLE (n&#x2009;=&#x2009;73) was characterized.</AbstractText><AbstractText Label="RESULTS">The oral microbial diversity of SLE was increased, and the microbial community was different between SLE and healthy controls. The genera Prevotella and Veillonella were enriched, while Streptococcus and Porphyromonas were reduced in SLE. In addition, an increase was noted in 27 predicted microbial functions, while a decrease was noted in 34 other functions. Thirty-nine operational taxonomy units (OTUs) were identified to be related with seven clinical indicators. Two OTUs were identified to construct a classifier, which yielded area under the curve values of 0.9166 (95% CI 0.8848-0.9483, p&#x2009;&lt;&#x2009;0.0001), 0.8422 (95% CI 0.7687-0.9157, p&#x2009;&lt;&#x2009;0.0001), and 0.8406 (95% CI 0.7677-0.9135, p&#x2009;&lt;&#x2009;0.0001) in the derivation, validation, and cross-regional validation groups, respectively. Moreover, as disease activity increased, Abiotrophia and Lactobacillales increased, while Phyllobacterium and unclassified Micrococcusaceae decreased. Finally, nine OTUs were selected to construct a classifier distinguishing posttreatment SLE patients from healthy controls, which achieved a diagnostic efficacy of 0.9942 (95% CI 0.9884-1, p&#x2009;&lt;&#x2009;0.0001).</AbstractText><AbstractText Label="CONCLUSIONS">Our study comprehensively characterizes the oral microbiome of SLE and shows the potential of the oral microbiota as a non-invasive diagnostic biomarker in SLE.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Guo</LastName><ForeName>Jinyan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Rheumatology and Immunology, The First Affiliated Hospital of Zhengzhou University, #1 Jianshe East Road, Zhengzhou, 450052, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Cui</LastName><ForeName>Guangying</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Infectious Disease, The First Affiliated Hospital of Zhengzhou University, #1 Jianshe East Road, Zhengzhou, 450052, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Gene Hospital of Henan Province, Precision Medicine Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Huang</LastName><ForeName>Wei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Rheumatology and Immunology, Hainan General Hospital, Haikou, 570100, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>Zhaohui</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Rheumatology and Immunology, The First Affiliated Hospital of Zhengzhou University, #1 Jianshe East Road, Zhengzhou, 450052, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Tianfang</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Rheumatology and Immunology, The First Affiliated Hospital of Zhengzhou University, #1 Jianshe East Road, Zhengzhou, 450052, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Guanmin</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Rheumatology and Immunology, The First Affiliated Hospital of Zhengzhou University, #1 Jianshe East Road, Zhengzhou, 450052, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Zhen</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Disease, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhan</LastName><ForeName>Yuwei</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Rheumatology and Immunology, Hainan General Hospital, Haikou, 570100, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ding</LastName><ForeName>Suying</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Health Management Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Shengyun</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Rheumatology and Immunology, The First Affiliated Hospital of Zhengzhou University, #1 Jianshe East Road, Zhengzhou, 450052, China. fccliusy@zzu.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Zujiang</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Infectious Disease, The First Affiliated Hospital of Zhengzhou University, #1 Jianshe East Road, Zhengzhou, 450052, China. johnyuem@zzu.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Gene Hospital of Henan Province, Precision Medicine Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China. johnyuem@zzu.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ren</LastName><ForeName>Zhigang</ForeName><Initials>Z</Initials><Identifier Source="ORCID">0000-0003-0798-3444</Identifier><AffiliationInfo><Affiliation>Department of Infectious Disease, The First Affiliated Hospital of Zhengzhou University, #1 Jianshe East Road, Zhengzhou, 450052, China. fccrenzg@zzu.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Gene Hospital of Henan Province, Precision Medicine Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China. fccrenzg@zzu.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Jinan Microecological Biomedicine Shandong Laboratory, Jinan, 250000, China. fccrenzg@zzu.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Transl Med</MedlineTA><NlmUniqueID>101190741</NlmUniqueID><ISSNLinking>1479-5876</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064307" MajorTopicYN="Y">Microbiota</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Characteristics</Keyword><Keyword MajorTopicYN="N">Diagnostic biomarker</Keyword><Keyword MajorTopicYN="N">Disease activity</Keyword><Keyword MajorTopicYN="N">Oral microbiota</Keyword><Keyword MajorTopicYN="N">Systemic lupus erythematosus</Keyword></KeywordList><CoiStatement>All authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>12</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>1</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>9</Day><Hour>0</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36755319</ArticleId><ArticleId IdType="pmc">PMC9905765</ArticleId><ArticleId IdType="doi">10.1186/s12967-023-03892-3</ArticleId><ArticleId IdType="pii">10.1186/s12967-023-03892-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Tsokos GC. Systemic lupus erythematosus. N Engl J Med. 2011;365:2110&#x2013;2121. doi: 10.1056/NEJMra1100359.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1100359</ArticleId><ArticleId IdType="pubmed">22129255</ArticleId></ArticleIdList></Reference><Reference><Citation>Rees F, Doherty M, Grainge MJ, Lanyon P, Zhang W. The worldwide incidence and prevalence of systemic lupus erythematosus: a systematic review of epidemiological studies. Rheumatology. 2017;56:1945&#x2013;1961. doi: 10.1093/rheumatology/kex260.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/kex260</ArticleId><ArticleId IdType="pubmed">28968809</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldblatt F, O'Neill SG. Clinical aspects of autoimmune rheumatic diseases. Lancet. 2013;382:797&#x2013;808. doi: 10.1016/S0140-6736(13)61499-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(13)61499-3</ArticleId><ArticleId IdType="pubmed">23993190</ArticleId></ArticleIdList></Reference><Reference><Citation>Belkaid Y, Naik S. Compartmentalized and systemic control of tissue immunity by commensals. Nat Immunol. 2013;14:646&#x2013;653. doi: 10.1038/ni.2604.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.2604</ArticleId><ArticleId IdType="pmc">PMC3845005</ArticleId><ArticleId IdType="pubmed">23778791</ArticleId></ArticleIdList></Reference><Reference><Citation>Human Microbiome Project Consortium Structure, function and diversity of the healthy human microbiome. Nature. 2012;486:207&#x2013;214. doi: 10.1038/nature11234.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature11234</ArticleId><ArticleId IdType="pmc">PMC3564958</ArticleId><ArticleId IdType="pubmed">22699609</ArticleId></ArticleIdList></Reference><Reference><Citation>Nenci A, Becker C, Wullaert A, Gareus R, van Loo G, Danese S, Huth M, Nikolaev A, Neufert C, Madison B, et al. Epithelial NEMO links innate immunity to chronic intestinal inflammation. Nature. 2007;446:557&#x2013;561. doi: 10.1038/nature05698.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature05698</ArticleId><ArticleId IdType="pubmed">17361131</ArticleId></ArticleIdList></Reference><Reference><Citation>Ley RE, Peterson DA, Gordon JI. Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell. 2006;124:837&#x2013;848. doi: 10.1016/j.cell.2006.02.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2006.02.017</ArticleId><ArticleId IdType="pubmed">16497592</ArticleId></ArticleIdList></Reference><Reference><Citation>Parks CG, de Santos ASE, Barbhaiya M, Costenbader KH. Understanding the role of environmental factors in the development of systemic lupus erythematosus. Best Pract Res Clin Rheumatol. 2017;31:306&#x2013;320. doi: 10.1016/j.berh.2017.09.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.berh.2017.09.005</ArticleId><ArticleId IdType="pmc">PMC5729939</ArticleId><ArticleId IdType="pubmed">29224673</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo M, Wang H, Xu S, Zhuang Y, An J, Su C, Xia Y, Chen J, Xu ZZ, Liu Q, et al. Alteration in gut microbiota is associated with dysregulation of cytokines and glucocorticoid therapy in systemic lupus erythematosus. Gut Microbes. 2020;11:1758&#x2013;1773. doi: 10.1080/19490976.2020.1768644.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/19490976.2020.1768644</ArticleId><ArticleId IdType="pmc">PMC7524333</ArticleId><ArticleId IdType="pubmed">32507008</ArticleId></ArticleIdList></Reference><Reference><Citation>Lippens C, Duraes FV, Dubrot J, Brighouse D, Lacroix M, Irla M, Aubry-Lachainaye JP, Reith W, Mandl JN, Hugues S. IDO-orchestrated crosstalk between pDCs and Tregs inhibits autoimmunity. J Autoimmun. 2016;75:39&#x2013;49. doi: 10.1016/j.jaut.2016.07.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2016.07.004</ArticleId><ArticleId IdType="pmc">PMC5127883</ArticleId><ArticleId IdType="pubmed">27470005</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf3;pez P, de Paz B, Rodr&#xed;guez-Carrio J, Hevia A, S&#xe1;nchez B, Margolles A, Su&#xe1;rez A. Th17 responses and natural IgM antibodies are related to gut microbiota composition in systemic lupus erythematosus patients. Sci Rep. 2016;6:24072. doi: 10.1038/srep24072.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep24072</ArticleId><ArticleId IdType="pmc">PMC4820712</ArticleId><ArticleId IdType="pubmed">27044888</ArticleId></ArticleIdList></Reference><Reference><Citation>Li R, Meng X, Chen B, Zhao L, Zhang X. Gut microbiota in lupus: a butterfly effect? Curr Rheumatol Rep. 2021;23:27. doi: 10.1007/s11926-021-00986-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11926-021-00986-z</ArticleId><ArticleId IdType="pubmed">33864162</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodr&#xed;guez-Carrio J, L&#xf3;pez P, S&#xe1;nchez B, Gonz&#xe1;lez S, Gueimonde M, Margolles A, de Los Reyes-Gavil&#xe1;n CG, Su&#xe1;rez A. Intestinal dysbiosis is associated with altered short-chain fatty acids and serum-free fatty acids in systemic lupus erythematosus. Front Immunol. 2017;8:23. doi: 10.3389/fimmu.2017.00023.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2017.00023</ArticleId><ArticleId IdType="pmc">PMC5253653</ArticleId><ArticleId IdType="pubmed">28167944</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L, Qing P, Yang H, Wu Y, Liu Y, Luo Y. Gut microbiome and metabolites in systemic lupus erythematosus: link mechanisms and intervention. Front Immunol. 2021;12:686501. doi: 10.3389/fimmu.2021.686501.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.686501</ArticleId><ArticleId IdType="pmc">PMC8319742</ArticleId><ArticleId IdType="pubmed">34335588</ArticleId></ArticleIdList></Reference><Reference><Citation>Hevia A, Milani C, L&#xf3;pez P, Cuervo A, Arboleya S, Duranti S, Turroni F, Gonz&#xe1;lez S, Su&#xe1;rez A, Gueimonde M, et al. Intestinal dysbiosis associated with systemic lupus erythematosus. mBio. 2014;5:e01548&#x2013;01514. doi: 10.1128/mBio.01548-14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.01548-14</ArticleId><ArticleId IdType="pmc">PMC4196225</ArticleId><ArticleId IdType="pubmed">25271284</ArticleId></ArticleIdList></Reference><Reference><Citation>He Z, Shao T, Li H, Xie Z, Wen C. Alterations of the gut microbiome in Chinese patients with systemic lupus erythematosus. Gut Pathog. 2016;8:64. doi: 10.1186/s13099-016-0146-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13099-016-0146-9</ArticleId><ArticleId IdType="pmc">PMC5146896</ArticleId><ArticleId IdType="pubmed">27980687</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen BD, Jia XM, Xu JY, Zhao LD, Ji JY, Wu BX, Ma Y, Li H, Zuo XX, Pan WY, et al. An autoimmunogenic and proinflammatory profile defined by the gut microbiota of patients with untreated systemic lupus erythematosus. Arthritis Rheumatol. 2021;73:232&#x2013;243. doi: 10.1002/art.41511.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.41511</ArticleId><ArticleId IdType="pubmed">33124780</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Wang HF, Li X, Li HX, Zhang Q, Zhou HW, He Y, Li P, Fu C, Zhang XH, et al. Disordered intestinal microbes are associated with the activity of systemic lupus erythematosus. Clin Sci. 2019;133:821&#x2013;838. doi: 10.1042/CS20180841.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/CS20180841</ArticleId><ArticleId IdType="pubmed">30872359</ArticleId></ArticleIdList></Reference><Reference><Citation>Azzouz D, Omarbekova A, Heguy A, Schwudke D, Gisch N, Rovin BH, Caricchio R, Buyon JP, Alekseyenko AV, Silverman GJ. Lupus nephritis is linked to disease-activity associated expansions and immunity to a gut commensal. Ann Rheum Dis. 2019;78:947&#x2013;956. doi: 10.1136/annrheumdis-2018-214856.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2018-214856</ArticleId><ArticleId IdType="pmc">PMC6585303</ArticleId><ArticleId IdType="pubmed">30782585</ArticleId></ArticleIdList></Reference><Reference><Citation>Paster BJ, Boches SK, Galvin JL, Ericson RE, Lau CN, Levanos VA, Sahasrabudhe A, Dewhirst FE. Bacterial diversity in human subgingival plaque. J Bacteriol. 2001;183:3770&#x2013;3783. doi: 10.1128/JB.183.12.3770-3783.2001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JB.183.12.3770-3783.2001</ArticleId><ArticleId IdType="pmc">PMC95255</ArticleId><ArticleId IdType="pubmed">11371542</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, Zhang D, Jia H, Feng Q, Wang D, Liang D, Wu X, Li J, Tang L, Li Y, et al. The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment. Nat Med. 2015;21:895&#x2013;905. doi: 10.1038/nm.3914.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.3914</ArticleId><ArticleId IdType="pubmed">26214836</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao E, Mattos M, Vieira GHA, Chen S, Corr&#xea;a JD, Wu Y, Albiero ML, Bittinger K, Graves DT. Diabetes enhances IL-17 expression and alters the oral microbiome to increase its pathogenicity. Cell Host Microbe. 2017;22:120&#x2013;128.e124. doi: 10.1016/j.chom.2017.06.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2017.06.014</ArticleId><ArticleId IdType="pmc">PMC5701758</ArticleId><ArticleId IdType="pubmed">28704648</ArticleId></ArticleIdList></Reference><Reference><Citation>Flemer B, Warren RD, Barrett MP, Cisek K, Das A, Jeffery IB, Hurley E, O'Riordain M, Shanahan F, O'Toole PW. The oral microbiota in colorectal cancer is distinctive and predictive. Gut. 2018;67:1454&#x2013;1463. doi: 10.1136/gutjnl-2017-314814.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2017-314814</ArticleId><ArticleId IdType="pmc">PMC6204958</ArticleId><ArticleId IdType="pubmed">28988196</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren Z, Wang H, Cui G, Lu H, Wang L, Luo H, Chen X, Ren H, Sun R, Liu W, et al. Alterations in the human oral and gut microbiomes and lipidomics in COVID-19. Gut. 2021;70:1253&#x2013;1265. doi: 10.1136/gutjnl-2020-323826.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2020-323826</ArticleId><ArticleId IdType="pmc">PMC8042598</ArticleId><ArticleId IdType="pubmed">33789966</ArticleId></ArticleIdList></Reference><Reference><Citation>Li BZ, Zhou HY, Guo B, Chen WJ, Tao JH, Cao NW, Chu XJ, Meng X. Dysbiosis of oral microbiota is associated with systemic lupus erythematosus. Arch Oral Biol. 2020;113:104708. doi: 10.1016/j.archoralbio.2020.104708.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.archoralbio.2020.104708</ArticleId><ArticleId IdType="pubmed">32203722</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Meulen TA, Harmsen HJM, Vila AV, Kurilshikov A, Liefers SC, Zhernakova A, Fu J, Wijmenga C, Weersma RK, de Leeuw K, et al. Shared gut, but distinct oral microbiota composition in primary Sj&#xf6;gren&#x2019;s syndrome and systemic lupus erythematosus. J Autoimmun. 2019;97:77&#x2013;87. doi: 10.1016/j.jaut.2018.10.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2018.10.009</ArticleId><ArticleId IdType="pubmed">30416033</ArticleId></ArticleIdList></Reference><Reference><Citation>Corr&#xea;a JD, Calderaro DC, Ferreira GA, Mendon&#xe7;a SM, Fernandes GR, Xiao E, Teixeira AL, Leys EJ, Graves DT, Silva TA. Subgingival microbiota dysbiosis in systemic lupus erythematosus: association with periodontal status. Microbiome. 2017;5:34. doi: 10.1186/s40168-017-0252-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40168-017-0252-z</ArticleId><ArticleId IdType="pmc">PMC5359961</ArticleId><ArticleId IdType="pubmed">28320468</ArticleId></ArticleIdList></Reference><Reference><Citation>Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40:1725. doi: 10.1002/art.1780400928.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.1780400928</ArticleId><ArticleId IdType="pubmed">9324032</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren Z, Li A, Jiang J, Zhou L, Yu Z, Lu H, Xie H, Chen X, Shao L, Zhang R, et al. Gut microbiome analysis as a tool towards targeted non-invasive biomarkers for early hepatocellular carcinoma. Gut. 2019;68:1014&#x2013;1023. doi: 10.1136/gutjnl-2017-315084.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2017-315084</ArticleId><ArticleId IdType="pmc">PMC6580753</ArticleId><ArticleId IdType="pubmed">30045880</ArticleId></ArticleIdList></Reference><Reference><Citation>Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum. 1992;35:630&#x2013;640. doi: 10.1002/art.1780350606.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.1780350606</ArticleId><ArticleId IdType="pubmed">1599520</ArticleId></ArticleIdList></Reference><Reference><Citation>Fanouriakis A, Kostopoulou M, Alunno A, Aringer M, Bajema I, Boletis JN, Cervera R, Doria A, Gordon C, Govoni M, et al. 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus. Ann Rheum Dis. 2019;78:736&#x2013;745. doi: 10.1136/annrheumdis-2019-215089.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2019-215089</ArticleId><ArticleId IdType="pubmed">30926722</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren Z, Fan Y, Li A, Shen Q, Wu J, Ren L, Lu H, Ding S, Ren H, Liu C, et al. Alterations of the human gut microbiome in chronic kidney disease. Adv Sci. 2020;7:2001936. doi: 10.1002/advs.202001936.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/advs.202001936</ArticleId><ArticleId IdType="pmc">PMC7578882</ArticleId><ArticleId IdType="pubmed">33101877</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei Y, Li Y, Yan L, Sun C, Miao Q, Wang Q, Xiao X, Lian M, Li B, Chen Y, et al. Alterations of gut microbiome in autoimmune hepatitis. Gut. 2020;69:569&#x2013;577. doi: 10.1136/gutjnl-2018-317836.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2018-317836</ArticleId><ArticleId IdType="pubmed">31201284</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C, Hemme C, Beleno J, Shi ZJ, Ning D, Qin Y, Tu Q, Jorgensen M, He Z, Wu L, Zhou J. Oral microbiota of periodontal health and disease and their changes after nonsurgical periodontal therapy. Isme j. 2018;12:1210&#x2013;1224. doi: 10.1038/s41396-017-0037-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41396-017-0037-1</ArticleId><ArticleId IdType="pmc">PMC5932080</ArticleId><ArticleId IdType="pubmed">29339824</ArticleId></ArticleIdList></Reference><Reference><Citation>Gergely P, Jr, Grossman C, Niland B, Puskas F, Neupane H, Allam F, Banki K, Phillips PE, Perl A. Mitochondrial hyperpolarization and ATP depletion in patients with systemic lupus erythematosus. Arthritis Rheum. 2002;46:175&#x2013;190. doi: 10.1002/1529-0131(200201)46:1&lt;175::AID-ART10015&gt;3.0.CO;2-H.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1529-0131(200201)46:1&lt;175::AID-ART10015&gt;3.0.CO;2-H</ArticleId><ArticleId IdType="pmc">PMC4020417</ArticleId><ArticleId IdType="pubmed">11817589</ArticleId></ArticleIdList></Reference><Reference><Citation>Chodari L, Dilsiz Aytemir M, Vahedi P, Alipour M, Vahed SZ, Khatibi SMH, Ahmadian E, Ardalan M, Eftekhari A. Targeting mitochondrial biogenesis with polyphenol compounds. Oxid Med Cell Longev. 2021;2021:4946711. doi: 10.1155/2021/4946711.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2021/4946711</ArticleId><ArticleId IdType="pmc">PMC8289611</ArticleId><ArticleId IdType="pubmed">34336094</ArticleId></ArticleIdList></Reference><Reference><Citation>Perl A, Hanczko R, Lai ZW, Oaks Z, Kelly R, Borsuk R, Asara JM, Phillips PE. Comprehensive metabolome analyses reveal N-acetylcysteine-responsive accumulation of kynurenine in systemic lupus erythematosus: implications for activation of the mechanistic target of rapamycin. Metabolomics. 2015;11:1157&#x2013;1174. doi: 10.1007/s11306-015-0772-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11306-015-0772-0</ArticleId><ArticleId IdType="pmc">PMC4559110</ArticleId><ArticleId IdType="pubmed">26366134</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen P, Lin W, Deng X, Ba X, Han L, Chen Z, Qin K, Huang Y, Tu S. Potential implications of quercetin in autoimmune diseases. Front Immunol. 2021;12:689044. doi: 10.3389/fimmu.2021.689044.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.689044</ArticleId><ArticleId IdType="pmc">PMC8260830</ArticleId><ArticleId IdType="pubmed">34248976</ArticleId></ArticleIdList></Reference><Reference><Citation>Eftekhari A, Hasanzadeh A, Khalilov R, Hosainzadegan H, Ahmadian E, Eghbal MA. Hepatoprotective role of berberine against paraquat-induced liver toxicity in rat. Environ Sci Pollut Res Int. 2020;27:4969&#x2013;4975. doi: 10.1007/s11356-019-07232-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11356-019-07232-1</ArticleId><ArticleId IdType="pubmed">31845254</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>